Zimmermann Carolyne 4
4 · 4D Molecular Therapeutics Inc. · Filed Feb 3, 2022
Insider Transaction Report
Form 4
Zimmermann Carolyne
Chief Business Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-02-01+35,000→ 35,000 totalExercise: $15.78Exp: 2032-01-31→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]The shares underlying the stock option award shall vest and become exercisable as to 1/48th of the underlying shares on each monthly anniversary of February 1, 2022 (the "Vesting Commencement Date") while the grantee remains a service provider to the Company.